top of page
Reducing maternal and children mortality through the development of safe, effective and affordable vaccines against placental malaria
NEWS
New study makes economic case for placental malaria vaccine, with first-time mothers standing to benefit most
By integrating regionally relevant epidemiologic, clinical, and cost data, the findings show that a vaccine targeting women who have never been pregnant before could deliver strong value for money, even under conservative vaccine efficacy, uptake and price assumptions. . Women pregnant for the first time are at highest risk because they have not yet built up natural immunity, making them, and their babies, the most important group to protect.
Jun 2
Understanding communities to improve vaccine uptake: new EVI-led study sheds light onto malaria-in-pregnancy vaccine acceptance in Malawi
A new publication in Vaccines reflects this commitment. Led by EVI in collaboration with the Malawi University of Science and Technology (MUST), a community-based cross-sectional survey was conducted among women of reproductive age in southern Malawi.
Apr 24
A roadmap for Malaria-in-pregnancy vaccines: ADVANCE-VAC4PM Workshop findings now published
The workshop integrated scientific, regulatory, cost-effectiveness, and socio-behavioural perspectives, providing a platform for coordinated dialogue among global stakeholders on development, evaluation, and implementation strategies.
Mar 30
bottom of page